Dietary Bioactives and Human Prostate Carcinogenesis DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Kristen Michelle Roberts, MS The Ohio State University Nutrition Program The Ohio State University 2015 Dissertation Committee: Steven Clinton “Advisor” Colleen Spees Steven Schwartz Martha Belury Copyright by Kristen Michelle Roberts 2015 Abstract It is estimated that dietary risk factors contribute to one in three cancers in Western nation. Prostate cancer (PCa) is associated with an affluent dietary pattern and lifestyle typical of North America and Northern Europe. Diets limited in fruits and vegetables are one characteristic of these high risk nations. Although difficult to study epidemiologically, a number of phytochemicals found in various fruits and vegetables, including berries, have been shown in laboratory studies (in vitro and with rodent models) to have anti-cancer activity. At OSU, the last decade has seen a focus upon black raspberries (BRB), a rich source of bioactive phytochemicals, and a crop of substantial importance to the state. BRB contain high concentrations of various polyphenols, of which ellagitannins and anthocyanins are best known. We propose to examine the potential of BRB to impact human PCa by fully characterizing a consistent BRB food product that is rich in phytochemicals, safe, and provides excellent compliance. We tested two novel food products (nectar and a confection) in two doses (low and high) in men with localized PCa, who have selected surgical prostatectomy as curative therapy. Various ellagitannin metabolites were measured by HPLC/MS/MS in the blood, urine, and prostate tissue. Most critically, we had three control groups (typical American diet, low polyphenol diet, and low ellagitannin diet) as no studies have thus far carefully defined by HPLC/MS/MS the background pattern/quantity of “berry derived” ii phytochemicals in blood, urine, and tissue. Lastly, the exploration of the vascular architecture (VA) in these men and two additional cohorts was investigated to determine the potential for VA being a biomarker for nutrition intervention studies. We have concluded from this data that our BRB food products deliver a consistent bioactive profile, are safe and have excellent compliance in a 4-week intervention trial. Quantified urolithins in the urine of the men was consistent with baseline diet ellagitannin intake and the dose of the BRB food product. Lastly, utilizing the vascular architecture as a biomarker for nutrition intervention studies is still in its infancy. Measurement of the vascular architecture is dependent upon the aggressiveness of the PCa, the endothelial cell marker used to identify the blood vessels and the technology used to analyze the architecture. iii Dedication This dissertation work is dedicated to my loving and supportive husband who encouraged me to pursue my academic dreams and to my family for providing me with the foundation to be independent and driven allowing me to achieve my goals. I love you all. iv Acknowledgments First and foremost I want to thank my advisor Steven Clinton. It has been an honor and privilege to work under the mentorship of such an accomplished leader who is dedicated to elucidating the link between diet and cancer for cancer prevention. I would also like to thank Drs. Elizabeth Grainger and Jennifer Thomas-Ahner. Thank you Beth for exemplifying professionalism in every aspect of your career and the invaluable guidance you offered throughout my doctoral degree and to Jen for the countless hours of education you provided which allowed me to transition from a clinical dietitian to a translational scientist. I can’t thank you both enough for your dedication and guidance throughout this process. I would also like to thank Dr. Nancy Moran for pushing me to be a better scientist and asking the tough questions! Last, but not least I want to thank my fellow students and colleagues, Dr. Lei Wan, Ashley Schmitz, Christi Simpson and Junnan Gu for their unconditional support over the years. v Vita June 1999…………………………………...Crestwood High School 2003................................................................B.S. Dietetics, Bowling Green State University 2005................................................................M.S. Human Nutrition, Arizona State University 2011 to present ..............................................Fellow, Department of Human Nutrition, The Ohio State University Publications Winham D, Johnston C, Rhoda K. Maternal Weight Gain is Associated with Infant Insulin Concentrations During the 1st Year of Life. Diabetes Care. 2006. 29:949. Rhoda KM, Chhatriwalla EG, Parekh NR. Transitional Feeding: Challenges and Approaches. Support Line. 2008. 30:21-28. Rhoda K, Parekh N, Lennon E, Kirby D, Quintini C, Steiger E, Shay-Downer C. The Multidisciplinary Approach to the Care of Intestinal Failure at a Tertiary Care Facility. Nutr Clin Prac. 2009. 25(2):183-204. Shatnawei A, Parekh N, Rhoda K, et al. Intestinal Failure Management at the Cleveland Clinic. Arch Surg. 2010. 145(6):521-527. Rhoda KM, Suryadevara S, Steiger E. “Home Parenteral Nutrition.” In: Dudrick S, Sanchez J. (Eds.) Surgical Clinics of North America. 2011. 91:913-932. vi Rhoda K, Porter M. Developing a Plan of Care for Fluid and Electrolyte Management. Support Line. 2011. 33(3):7-12. Rhoda K, Porter MJ. Fluid and Electrolyte Management: Putting a Plan in Motion. J Parenter Enteral Nutr. 2011. 35(6): 675-685. John BK, Khan MA, Speerhas R, Rhoda K, et al. Ethanol lock therapy in reducing catheter-related blood stream infections in adult home parenteral nutrition patients: results of a retrospective study. J Parenter Enteral Nutr. 2012. 36:603-610. Barco KT, Alberino MJ, Roberts KM, Wolff J, et al. “Common Gastrointestinal Symptoms.” In: Matarese LE, Mullin GE, Raymond JL. (Eds.) The Health Professional’s Guide to Gastrointestinal Nutrition. 2014. 63-78. Fields of Study Major Field: The Ohio State University Nutrition Program Specialization: Biomedical Clinical and Translational Science vii Table of Contents Abstract……………………………………………………………………………………ii Dedication………………………………………………………………………………...iv Acknowledgments…………………………………………………………………………v Vita………………………………………………………………………………………..vi List of Tables…...................................................................................................................x List of Figures………………………………………………………………………...…xiii Chapter 1: Introduction to Dietary Bioactives and Prostate Cancer……….…...................1 Chapter 2: Introduction to Berry Polyphenols and Prostate Cancer……………………..12 Chapter 3: Urinary polyphenol metabolites in men on usual diet, a low polyphenol diet, or low ellagitannin diet..…………………………………………………………………20 Chapter 4: Functional Food Intervention and Prostate Carcinogenesis……………….....51 Chapter 5: Introduction: Angiogenesis in Epidemiology and Intervention Studies……………………………………………………………………………………76 Chapter 6: Health Professionals Follow-up Study and Angiogenesis………………...…86 Chapter 7: Tomato-Soy Juice and Angiogenesis……………………...………………..119 Chapter 8: Integration of Angiogenesis Cohorts: lessons learned……………...……....145 Chapter 9: Final Summary on Dietary Bioactives and Prostate Carcinogenesis……….160 viii References………………………………………………………………………………162 Appendix A: Usual Diet……………………………………………………………...…170 Appendix B: Low Polyphenol Diet……………………...……………………………...172 Appendix C: Low Ellagitannin Diet…………………………………………................174 ix
Description: